IRBESARTAN IN THE CLINICAL PRACTICE

IRBESARTAN IN THE CLINICAL PRACTICE

Show other versions (1)

<p>Only few hypertensive patients are treated effectively despite of the variety of antihypertensive drugs. There is a linear relationship between blood pressure levels and the risk of complications (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers...

Full description

Bibliographic Details
Main Authors: V. I. Podzolkov, A. I. Tarzimanova
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
ирбесартан
блокаторы рецепторов к ангиотензину
артериальная гипертензия
нефропротективный эффект
Online Access:http://www.rpcardio.ru/jour/article/view/306
Description
Summary:<p>Only few hypertensive patients are treated effectively despite of the variety of antihypertensive drugs. There is a linear relationship between blood pressure levels and the risk of complications (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first-line drugs for initial therapy of uncomplicated hypertension. Irbesartan is one of the most studied angiotensin receptor blockers. Data supporting the high antihypertensive and nephroprotection efficacy of irbesartan as well as its ability to reduce cardiovascular risk in hypertensive patients are presented.</p>
ISSN:1819-6446
2225-3653

Similar Items